A year-long extended release nanoformulated cabotegravir prodrug

Kulkarni, TA; Bade, AN; Sillman, B; Shetty, BLD; Wojtkiewicz, MS; Gautam, N; Hilaire, JR; Sravanam, S; Szlachetka, A; Lamberty, BG; Morsey, BM; Fox, HS; Alnouti, Y; McMillan, JM; Mosley, RL; Meza, J; Domanico, PL; Yue, TY; Moore, G; Edagwa, BJ; Gendelman, HE

Edagwa, BJ; Gendelman, HE (corresponding author), Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA.; Gendelman, HE (corresponding author), Univ Nebraska Med Ctr, Dept Pharmaceut Sci, Omaha, NE 68198 USA.

NATURE MATERIALS, 2020; 19 (8): 910

Abstract

Long-acting cabotegravir (CAB) extends antiretroviral drug administration from daily to monthly. However, dosing volumes, injection site reactions and......

Full Text Link